vcfirmsdirectory.com

Venture capital · Growth stage · Est. 1998

Wellington

Munich-based European venture capital firm backing early- and growth-stage life science companies, including therapeutics, medical devices, diagnostics and digital health. Founded in 1998, it previously also invested in technology companies.

Munich · ZurichRegistered · München
New investments · 12 months
Fund vehiclesPublic
5
5 active · EuVECA
First chequePublic
€2M–€20M
From the firm’s website
Active portfolio
FreeRegistry entries, fund vehicles and filingsPROEverything we enrich: deals, team, events and signals
Updated 8 Nov 2026, 05:07 CETSources: ESMA register · wellington-partners.com · SEC adviser filings

Investment activity

Round-by-round activity is part of PRO

See every round Wellington joined

Monthly deal flow, follow-ons, fund closes and exits.

Key signal this week

See all signals

Is Wellington right for your round?

Is Wellington a fit for your round?

Match your sector, round, size and region against where they invest, and see who to approach.

Key stats

Fund vehiclesPublic
5
5 active · EuVECA
ESMA register and SEC adviser filings
On the register sincePublic
2023
26 Sep 2023
ESMA register of EuVECA managers
First chequePublic
€2M–€20M
From the firm’s website
wellington-partners.com
Core stage
New deals per year
Lead rate
Active portfolio
Exits

Fund cycle Public record

Fund vehicles on public registers (ESMA register and SEC adviser filings).

Wellington Partners Life Science VI GmbH & Co. KGEuVECA · Active · Germany
Wellington Partners Life Sciences SPV I GmbH & Co. KGEuVECA · Active · Germany
Wellington Partners Life Sciences SPV II GmbH & Co. KGEuVECA · Active · Germany
Wellington Partners Life Sciences SPV III GmbH & Co. KGEuVECA · Active · Germany
Wellington Partners Life Sciences V GmbH & Co. KGEuVECA · Active · Germany
Deployed (new cheques)
Next fund expected

Latest investments

BetaRounds Wellington joined, from press and the firm’s own posts.

DateCompanyRoundRound sizeRoleAlongside

1 round in the last 12 months

Round sizes, Wellington’s role and who invested alongside.

Round-by-round history is part of PRO

Notable portfolio

UroMemsThemis BioscienceImCheckCorFlow TherapeuticsSidekickConfoActelionAdrenomedAdvanced Medical Balloons (AMB)Definiensand 6 more

Portfolio and exits

Every company Wellington backed and how the exits played out.

Where the money goes

Share of companies at first investment, from the rounds we track.

Where Wellington puts its money

Sector, country and stage mix across every first cheque.

Investment team

The investment team

Partners, principals and investors, with their city, focus and how to reach them.

Where to meet Wellington

Events where Wellington’s team spoke or showed up, from event programmes, press and the firm’s own posts.

Where to meet Wellington’s partners

The events they speak at, your next chance to meet them, and which ones founders can get into.

Signals

Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.

26 Feb 2026New deal
8 Oct 2025RegisterWellington Partners Management GmbH registered as a EuVECA manager.ESMA register · public record
17 Feb 2025Fund filingForm ADV filed by WELLINGTON PARTNERS.SEC Form ADV · public record
26 Jul 2024New deal
25 Jun 2024New deal
26 Sep 2023RegisterWellington Partners Life Science Venture Capital Management GmbH registered as a EuVECA manager.ESMA register · public record

Founders also look at

Frequently asked questions

Wellington is based in München, Germany. It also has offices in Munich and Zurich. Its registered address is Türkenstraße 5, 80333, München.

In 1998.

5 fund vehicles are on public registers (ESMA register and SEC adviser filings), including Wellington Partners Life Science VI GmbH & Co. KG, Wellington Partners Life Sciences SPV I GmbH & Co. KG and Wellington Partners Life Sciences SPV II GmbH & Co. KG.

Stages: Growth. Sectors: Biotech, Medtech, Health tech, Life sciences. From the firm’s own website.

€2M to €20M per investment, according to the firm’s own website.

Wellington lists 16 portfolio companies on its website, including UroMems, Themis Bioscience, ImCheck, CorFlow Therapeutics and Sidekick.

Firms whose websites list some of the same companies include 415 Capital, ALBION INVESTMENT MANAGEMENT LTD and Asabys Partners.

Know before Wellington’s next round is announced.

PRO tracks Wellington’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.

WellingtonGet Wellington’s signals the day they landMonitor

Search the directory

Type a firm's name, a city or a country.